Advertisement

International Journal of Clinical Oncology

, Volume 24, Issue 1, pp 34–40 | Cite as

Preservation of fertility of adult male cancer patients treated with chemotherapy

  • Koji KawaiEmail author
  • Hiroyuki Nishiyama
Invited Review Article

Abstract

Chemotherapy-induced gonadal dysfunction resulting in transient or persistent infertility depends on the type of drugs and cumulative dose, and it is an important long-term complication, especially for adolescent and young adult (AYA) cancer patients. Due to its importance, a clinical practice guideline for fertility preservation in childhood and AYA cancer patients was published by the Japan Society of Clinical Oncology (JSCO) in 2017. Although the precise mechanisms remain unclear, several studies reported that the cancer itself, not the cancer treatment, adversely affected semen quality. It is reported that that poor pretreatment semen quality is commonly seen in various cancer types including testicular cancer, leukemia, brain tumor, and sarcoma. Fortunately, however, even men with poor sperm quality can be candidates for sperm cryopreservation due to recent advances in assisted reproductive technology (ART) and sperm banking techniques. Therefore, the JSCO guideline and others recommend that sperm cryopreservation should be considered as early as possible when patients are planning to undergo treatment that may render them infertile. The previous studies showed that testicular cancer and hematological tumors are the two leading types of cancer among patients who requested sperm cryopreservation. This is followed by bone and soft-tissue tumors and central nervous system tumors and others. Although the efficacy of postchemotherapy testicular sperm extraction (TESE)/intracytoplasmic sperm injection (ICSI) was reported recently, it is quite important to inform patients of the potential risk of treatment-induced infertility and the possibility of fertility preservation by sperm cryopreservation before chemotherapy.

Keywords

Infertility Fertility preservation Sperm cryopreservation Adolescent and young adult 

Notes

Compliance with ethical standards

Conflict of interest

No author has any conflict of interest.

References

  1. 1.
    NCCN Guideline (2018) Adolescent and young adult oncology, ver.2.2018, October 11, 2017, MS12–MS15. https://www.nccn.org/professionals/physician_gls/pdf/aya.pdf
  2. 2.
    Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931CrossRefGoogle Scholar
  3. 3.
    Loren AW, Mangu PB, Beck LN et al (2013) Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500–2510CrossRefGoogle Scholar
  4. 4.
    Tournaye H, Dohle GR, Barratt CL (2014) Fertility preservation in men with cancer. Lancet 384:1295–1301CrossRefGoogle Scholar
  5. 5.
    Japanese Society of Clinical Oncology (2017) JSCO Clinical practice guidelines 2017 for fertility preservation in childhood, adolescent, and young adults cancer patients. Kanehara, TokyoGoogle Scholar
  6. 6.
    Williams DH 4th, Karpman E, Sander JC (2009) Pretreatment semen parameters in men with cancer. J Urol 181:736–740CrossRefGoogle Scholar
  7. 7.
    Auger J, Sermondade N, Eustache F (2016) Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations. Basic Clin Androl 26:3.  https://doi.org/10.1186/s12610-016-0031-x Google Scholar
  8. 8.
    van der Kaaij MA, Heutte N, van Echten-Arends J (2009) Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trials. Haematologica 94:1691–1697CrossRefGoogle Scholar
  9. 9.
    Suzuki K, Shin T, Shimomura Y (2009) Spermatogenesis in tumor-bearing testes in germ cell testicular cancer patients. Hum Reprod 30:2853–2858Google Scholar
  10. 10.
    Meistrich ML (2013) Effects of chemotherapy and radiotherapy on spermatogenesis in humans. Fertil Steril 100:1180–1186CrossRefGoogle Scholar
  11. 11.
    Lorenzi E, Simonelli M, Santoro A (2016) Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue. Crit Rev Oncol Hematol 107:1–13CrossRefGoogle Scholar
  12. 12.
    Daudin M, Rives N, Walschaerts M et al (2015) Sperm cryopreservation in adolescents and young adults with cancer: results of the French national sperm banking network (CECOS). Fertil Steril. 103:478–486CrossRefGoogle Scholar
  13. 13.
    Yumura Y, Tsujimura A, Okada H et al (2018) Current status of sperm banking for young cancer patients in Japanese nationwide survey. Asian J Androl.  https://doi.org/10.4103/aja.aja_74_17 (in press) Google Scholar
  14. 14.
    Kobayashi H, Tamura K, Tai T et al (2017) Semen cryopreservation as an oncofertility treatment in 122 Japanese men with cancer: A decade-long study. Reprod Med Biol 16:320–324CrossRefGoogle Scholar
  15. 15.
    Depalo R, Falagario D, Masciandaro P et al (2016) Fertility preservation in males with cancer: 16-year monocentric experience of sperm banking and post-thaw reproductive outcomes. Ther Adv Med Oncol 8:412–420CrossRefGoogle Scholar
  16. 16.
    Petersen PM, Hansen SW, Giwercman A et al (1994) Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol 5:355–358CrossRefGoogle Scholar
  17. 17.
    Stephenson WT, Poirier SM, Rubin L et al (1995) Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin. J Clin Oncol 13:2278–2280CrossRefGoogle Scholar
  18. 18.
    Lampe H, Horwich A, Norman A et al (1997) Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15:239–245CrossRefGoogle Scholar
  19. 19.
    Pectasides D, Pectasides M, Farmakis D et al (2004) Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy. Eur Urol 45:187–193CrossRefGoogle Scholar
  20. 20.
    Gandini L, Sgrò P, Lombardo F et al (2006) Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients. Hum Reprod 21:2882–2889CrossRefGoogle Scholar
  21. 21.
    Brydøy M, Fosså SD, Klepp O et al (2005) Paternity following treatment for testicular cancer. J Natl Cancer Inst 97:1580–1588CrossRefGoogle Scholar
  22. 22.
    Kojima T, Kawai K, Tsuchiya K (2015) Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor. Int J Urol 22:923–927CrossRefGoogle Scholar
  23. 23.
    Viviani S, Santoro A, Ragni G (1985) Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 21:601–605CrossRefGoogle Scholar
  24. 24.
    Borgmann-Staudt A, Rendtorff R, Reinmuth S et al (2012) Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant 47:271–276CrossRefGoogle Scholar
  25. 25.
    Rovó A, Aljurf M, Chiodi S et al (2013) Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the late effects working party of the European group for blood and marrow transplantation. Haematologica 98:339–345CrossRefGoogle Scholar
  26. 26.
    van Casteren NJ, van Santbrink EJ, van Inzen W et al (2008) Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril 90:2245–2250CrossRefGoogle Scholar
  27. 27.
    Agarwal A, Ranganathan P, Kattal N et al (2004) Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril 81:342–348CrossRefGoogle Scholar
  28. 28.
    Ferrari S, Paffoni A, Filippi F et al (2016) Sperm cryopreservation and reproductive outcome in male cancer patients: a systematic review. Reprod Biomed Online 33:29–38CrossRefGoogle Scholar
  29. 29.
    Hamano I, Hatakeyama S, Ohyama C (2017) Fertility preservation of patients with testicular cancer. Reprod Med Biol 16:240–251CrossRefGoogle Scholar
  30. 30.
    Soda T, Okubo K, Ichioka K et al (2009) Sperm cryopreservation for cancer patients: 5-year experience in a private hospital in Japan. Hinyokika Kiyo 55:9–13Google Scholar
  31. 31.
    Suzuki K, Matuzaki J, Hattori Y (2007) Semen cryopreservation for patients with malignant or non-malignant disease: our 14-year experience. Hinyokika Kiyo 53:539–544Google Scholar
  32. 32.
    Meseguer M, Garrido N, Remohí J (2003) Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy. Hum Reprod 18:1281–1285CrossRefGoogle Scholar
  33. 33.
    Hsiao W, Stahl PJ, Osterberg EC (2011) Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience.J Clin Oncol. 29:1607–1611Google Scholar
  34. 34.
    Shiraishi K, Matsuyama H (2014) Microdissection testicular sperm extraction and salvage hormonal treatment in patients with postchemotherapy azoospermia. Urology 83:100–106CrossRefGoogle Scholar
  35. 35.
    Shin T, Kobayashi T, Shimomura Y (2016) Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy. Int J Clin Oncol 21:1167–1171CrossRefGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2018

Authors and Affiliations

  1. 1.Department of Urology, Faculty of MedicineUniversity of TsukubaTsukubaJapan

Personalised recommendations